3/2023: Is the patient actually failing on enzalutamide? A case report and issues to consider in enzalutamide-resistant oligoprogressive castrate-resistant prostate cancer
3/2023: Immune checkpoint inhibitors and combinations with other agents in cholangiocarcinoma
8/2022: Can thromboprophylaxis build a link for cancer patients undergoing surgical and / or chemotherapy treatment? The METHOS cohort study
2/2022: Systemic treatment of Ewing Sarcoma: Current Options and Future Perspectives
1/2022: Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives
12/2021: Case report: Combination of Olaparib with Chemotherapy in a patient with ATM-deficient colorectal cancer
10/2021: Case Report: Adenocarcinoma of the larynx with later hepatocellular differentiation
8/2021: Perforated appendicitis induced by pembrolizumab – A case report and review of the literature,
8/2021: An overview of current results with the Vincristine-Irinotecan-Temozolomide combination with or without Bevacizumab in pediatric, adolescense and adult solid tumors
7/2021: Central neurotoxicity induced by trastuzumab emtansine (T-DM1)-a case report
7/2021: High grade neuroendocrine carcinoma of the breast, first line and maintenance immunotherapy
6/2021: Immunotherapy for cholangiocarcinoma: a 2021 update
1/2021: Notable response of a young adult with recurrent glioblastoma multiforme to vincristine – irinotecan – temozolomide and bevacizumab
9/2020: Can thromboprophylaxis build a link for cancer patients undergoing surgical and / or chemotherapy treatment? Intermediate results from the METHOS study
1/2020: CNS Tumors in Adolescents and Young Adults: The Need for a Holistic Specialized Approach
